Lack of effect of L‐687,414 ((+)‐cis‐4‐methyl‐HA‐966)5 an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

British Journal of Pharmacology

Volumn 110, Issue 1, 1993, Pages 36-42

  Hargreaves, R J ^a   Rigby, M ^a   Smith, D ^a   Hill, R G ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

cerebral glucose metabolism; cortical neuronal morphology; dizocilpine; L 687,414; NMDA glycine; partial agonist

Indexed keywords

3 AMINO 1 HYDROXY 4 METHYL 2 PYRROLIDINONE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BRAIN CORTEX; CONTROLLED STUDY; DRUG BLOOD LEVEL; GLUCOSE METABOLISM; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; BLOOD GLUCOSE; BLOOD PRESSURE; BRAIN CHEMISTRY; CEREBRAL CORTEX; DEOXYGLUCOSE; DIZOCILPINE MALEATE; GLUCOSE; GLYCINE; HEART RATE; HEMODYNAMICS; MALE; NEURONS; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0027294037     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1993.tb13768.x     Document Type: Article

References (39)

1. Phencyclidine, dizocilpine and cerebrocortical neurons
2. The effects of acute and chronic treatment with dizocilpine on neuronal morphology in the rat CNS
3. The excitotoxin hypothesis in relation to cerebral ischaemia
4. Ketamine effects on local cerebral blood flow and metabolism in the rat
5. Methods for antagonising glutamate neurotoxicity
6. SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat cortical neurons
7. Age dependency of NMDA antagonist neurotoxicity
8. The glycine site on the NMDA receptor: pharmacology and involvement in NMDA receptor‐mediated neurodegeneration
9. Activities of 4‐methyl derivatives of HA‐966 at the glycine site of the N‐methyl‐d‐aspartate receptor from rat brain
10. Neuroprotective effects of MK‐801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation
11. Neuroprotective effects of the glycine site antagonist (+)cis‐4‐methyl‐H A‐966 (L‐687,414) in a rat focal ischaemia model
12. The neuroprotective action of dizocilpine (MK‐801) in the rat middle cerebral artery model of cerebral ischaemia
13. L‐687,414 ((+)‐cis‐4‐methyl‐HA‐966), an NMDA receptor antagonist acting at the glycine site, does not alter glucose metabolism or neuronal morphology at neuroprotective dose levels
14. Competitive as well as uncompetitive N‐methyl‐D‐aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism
15. A radioimmunoassay for the anticonvulsant and neuroprotective agent MK‐801
16. Lesions of the basal forebrain in rat selectivity impair the cortical vasodilation elicited from the cerebellar fastigial nucleus
17. Functional assessment of the actions of 4‐methyl derivatives of HA‐966 at the glycine site of the N‐methyl‐d‐aspartate receptor
18. Effects of MK‐801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane
19. Effects of NMDA antagonists, MK‐801 and CPP, upon local cerebral glucose use
20. Cardiovascular effects of the N‐methyl‐D‐aspartate receptor antagonist MK‐801 in conscious rats
21. Heat shock protein (HSP70) expression in focal brain damage
22. Ischaemic brain damage—prevention with competitive and non‐competitive antagonists of N‐methyl‐D‐aspartate receptors
23. Autoradiographic assessment of the effects of N‐methyl‐D‐aspartate (NMDA) receptor antagonists in vivo
24. Electrical stimulation of cerebellar fastigial nucleus increases cerebral cortical blood flow without change in local metabolism: evidence for an intrinsic system in brain for primary vasodilation
25. Differential effects of competitive and non‐competitive N‐methyl‐D‐aspartate antagonists on glucose use in the limbic system
26. The effects of N‐methyl‐D‐aspartate receptor blockade with MK‐801 upon the relationship between cerebral blood flow and glucose utilisation
27. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs
28. NMDA antagonist neurotoxicity: mechanism and prevention
29. Plasma profiles of ligands at the NMDA receptor complex after neuroprotective doses
30. The anti‐convulsant properties in the mouse of the glycine/NMDA receptor antagonist, L‐687,414
31. Effects of SL 82.0715, an NMDA receptor antagonist acting at the polyamine modulatory site, on local cerebral glucose use in rat brain
32. MK‐801 and ketamine induced heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex
33. Haloperidol and rimcazole prevent induction of the HPS70 heat shock gene in neurons injured by phencyclidine and MK‐801
34. The glycine‐site NMDA receptor antagonist, R‐(+)‐cis‐β‐methyl‐3‐amino‐1‐hydroxypyrrolid‐2‐one, L‐687,414 is anticonvulsant in baboons
35. 14C]deoxyglucose method for the measurement of local cerebal glucose utilization: theory, procedure and normal values in the conscious and anaesthetised albino rat
36. The effect of alpha‐adrenergic blockade on the cardiopulmonary response to ketamine
37. Relationship between expression of heat shock protein‐70 mRNA and histologic injury following focal ischaemia in rat brain
38. Ketamine—its pharmacology and therapeutic uses
39. Site for antagonism on the N‐methyl‐D‐aspartate receptor channel complex